The pharmaceutical industry's progress is intrinsically linked to the availability of high-purity chemical intermediates that serve as the foundational elements for drug synthesis. 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl (CAS No.: 210963-78-3) is a prime example of such a crucial fine chemical, indispensable for the development and manufacturing of various pharmaceutical products.

Chemical Properties and Applications

With the chemical formula C10H13ClN2O2 and a molecular weight of 228.67542, 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl is typically supplied as a white powder. Its specific chemical structure and reactivity make it a sought-after intermediate in complex organic synthesis, particularly for the creation of Active Pharmaceutical Ingredients (APIs). The versatility of this benzoic acid derivative allows it to be incorporated into diverse synthetic routes, contributing to the production of a wide range of therapeutic compounds.

The Importance of Reliable Manufacturing and Supply

For pharmaceutical manufacturers, securing a consistent and high-quality supply of intermediates is not just about cost; it's about ensuring the integrity and efficacy of the final drug product. A reliable manufacturer of 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, often found in chemical hubs like China, plays a pivotal role. They must adhere to stringent quality control measures to guarantee the purity and consistency of the intermediate, minimizing batch-to-batch variability. This dedication to quality is vital for meeting regulatory requirements and ensuring patient safety.

Procurement for R&D and Production

When pharmaceutical companies look to buy 4-[(Dimethylamino)iminomethyl]benzoic Acid HCl, they seek suppliers who can provide not only the product itself but also the necessary technical support and documentation. Access to Certificates of Analysis (CoA) and Material Safety Data Sheets (MSDS) is standard. Furthermore, establishing a dependable partnership with a manufacturer allows for seamless integration into research and development pipelines and scaled-up production processes. We pride ourselves on being a trusted source, offering this essential intermediate to support your pharmaceutical manufacturing goals.

Conclusion

4-[(Dimethylamino)iminomethyl]benzoic Acid HCl (CAS 210963-78-3) embodies the critical link between fine chemical manufacturing and pharmaceutical innovation. Its consistent demand highlights the need for reliable suppliers who can deliver on quality and availability. By understanding the importance of this intermediate and partnering with reputable manufacturers, the pharmaceutical sector can continue to advance the development of essential medicines.